Malignant Glioma
📧 Sign up to get email alerts when something new happens for Malignant Glioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-02-10Clinical Trial Update: HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma [Phase 2]
A Phase 2 trial evaluating HSV G207 with a single radiation dose for children with recurrent high-grade glioma has been withdrawn from Clini…
-
CLINICAL_TRIALS withdrawal · 2024-10-26Clinical Trial Update: Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer [Phase 1]
A Phase 1 trial investigating chemotherapy and donor stem cell transplantation for high-grade brain cancers has been withdrawn. The study in…
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with Glioblastoma [Phase 1]
A Phase 1 trial investigating dexamethasone and azeliragon for post-resection cerebral edema in glioblastoma patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-03-10Clinical Trial Update: MK-2206 for Recurrent Malignant Glioma [Phase 2]
Phase 2 trial of MK-2206 for recurrent malignant glioma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-11-13Clinical Trial Update: Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant Glioma [Phase 1, Phase 2]
A Phase I/II trial of intracerebral IL-13-PE38QQR infusions in pediatric patients with recurrent malignant glioma has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2014-09-22Clinical Trial Update: Patient Satisfaction, Efficacy and Compliance of Antiemetic Patch vs Pill in Malignant Glioma Patients [Phase 2]
The Phase 2 trial evaluating patient satisfaction, efficacy and compliance of an antiemetic patch versus an oral pill in malignant glioma pa…
-
CLINICAL_TRIALS withdrawal · 2012-02-22Clinical Trial Update: Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas [Phase 3]
A Phase 3 trial assessing procarbazine with isotretinoin for recurrent primary malignant gliomas has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2010-09-24Clinical Trial Update: Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas [Phase 1, Phase 2]
The Phase 1/2 clinical trial evaluating immunotoxin therapy for children with recurrent malignant gliomas has been withdrawn.